A Single Center Real-World Data Comparing Salvage Autologous Hematopoietic Stem-Cell Transplantation, Selinexor Combo and Elranatamab Alone Among Triple Class Refractory Myeloma Patients: Better Efficacy with Elranatamab
| Autor: | Cengiz Seval, Guldane, Yavuz, Gul, Sonmez, Gulcin Miyase, Arik, Goren, Yildirim, Fatma Selin, Toprak, Selami Kocak, Topçuoğlu, Pervin, Beksac, Meral |
|---|---|
| Zdroj: | In Blood 2 November 2023 142 Supplement 1:6668-6668 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|